Coley to outsource future drug discovery
After having to abandon a promising experimental hepatitis C vaccine and shedding over a fifth of its workforce, Coley Pharmaceutical has announced it will look to outsource future drug discovery.
After having to abandon a promising experimental hepatitis C vaccine and shedding over a fifth of its workforce, Coley Pharmaceutical has announced it will look to outsource future drug discovery.
Two companies have teamed-up to create what they claim is one of the world's fastest robotic packagers.
UK biotech company Verona Pharma has contracted fellow UK firm Onyx to manufacture supplies of its new hay fever drug candidate for forthcoming preclinical and clinical studies.
Viral vector manufacturer Lentigen has entered into a collaboration with Wave Biotech to gain access to disposable process and equipment expertise, which ties in with a shift in the bioprocess manufacturing sector towards using disposable systems.
PRA International has entered into an alliance with US Oncology Research, designed to accelerate the clinical development of new cancer treatments in the US.
Covance has again reported a healthy business performance with a 6.4 per cent increase in sales of $343m (€266m) for the fourth quarter of 2006.
Johnson Matthey has announced a reassuring business update ahead of its 31 March year-end, suggesting that Adderall is the driving force behind a recovery in its pharmaceutical materials business.
US-based firm Xcellerex yesterday announced it has completed the second half of a $20m (€15.4m) financing deal, raising $11m to speed up commercialisation of its innovative disposable manufacturing technology for vaccines and biotherapeutics.
Merck-Serono today announced the launch of easypod, the first electronic growth hormone injection device.